Cargando…
Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring
This manuscript summarizes the results of the consensus meeting composed of hematologists and cardiologists to establish recommendations for the prevention and follow-up of cardiovascular (CV) risk in patients with chronic myeloid leukemia (CML) treated with BCR-ABL tyrosine kinase inhibitors (TKIs)...
Autores principales: | Seguro, Fernanda Salles, Silva, Carolina Maria Pinto Domingues Carvalho, Moura, Carla Maria Boquimpani de, Conchon, Monika, Fogliatto, Laura, Funke, Vaneuza Araujo Moreira, Abdo, André, Macedo, Ariane Vieira Scarlatelli, Santos, Marilia Harumi Higushi dos, Saraiva, José Francisco Kerr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211634/ https://www.ncbi.nlm.nih.gov/pubmed/32631809 http://dx.doi.org/10.1016/j.htct.2020.04.009 |
Ejemplares similares
-
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
por: Boquimpani, Carla, et al.
Publicado: (2022) -
Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012
por: de Souza, Carmino Antonio, et al.
Publicado: (2012) -
Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment
por: Okumura, Lucas M., et al.
Publicado: (2015) -
Tratamento Direcionado ao Sistema Renina-Angiotensina-Aldosterona na Obesidade
por: Macedo, Ariane Vieira Scarlatelli
Publicado: (2020) -
COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience
por: Pagnano, Katia B, et al.
Publicado: (2020)